298 results
Page 4 of 15
8-K
EX-99.1
vv0bfwa
4 Aug 20
Launched ProFound AI™ Risk Offering After Receiving CE Mark in Europe
4:10pm
8-K
EX-10.2
y0oujcx
29 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.3
k44vqjnrlfzlp6 vk0i7
29 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.4
6i9q6c
29 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
jdk8dqydj85vw
11 May 20
Recent Equity Offering Strengthens Balance Sheet and Increases Operating Flexibility with focus on Brain Cancer Initiatives
4:24pm
8-K
EX-10.1
jyws07gammxjn hug1
27 Apr 20
Entry into a Material Definitive Agreement
5:21pm
424B5
vtlhx61d
24 Apr 20
Prospectus supplement for primary offering
5:11pm
8-K
EX-10.1
8h1ui
31 Mar 20
Entry into a Material Definitive Agreement
9:03am
8-K
EX-10.2
jubhg6zrgvwxs
31 Mar 20
Entry into a Material Definitive Agreement
9:03am
424B5
r919sxczqxr f07evs
31 Mar 20
Prospectus supplement for primary offering
9:01am
8-K
EX-99.1
v89goitnzo0 bwp2ij0c
28 Feb 20
Strong Q4 2019 revenue growth of 35% driven by a 39% increase in revenue from iCAD’s AI Cancer Detection segment
8:32am
8-K
EX-10.1
s9wffmeo2jw
17 Jan 20
Departure of Directors or Certain Officers
4:58pm